Literature DB >> 14512442

Enhanced synthesis of the oxysterol 24(S),25-epoxycholesterol in macrophages by inhibitors of 2,3-oxidosqualene:lanosterol cyclase: a novel mechanism for the attenuation of foam cell formation.

Andrea H Rowe1, Carmen A Argmann, Jane Y Edwards, Cynthia G Sawyez, Olivier H Morand, Robert A Hegele, Murray W Huff.   

Abstract

Oxysterols are key regulators of lipid metabolism and regulate gene expression by activating the liver X receptor (LXR). LXR plays a vital role in macrophage foam cell formation, a central event in atherosclerosis. It is known that addition of exogenous oxysterols to cultured macrophages activates LXR, leading to increased expression of ABCA1 and cholesterol efflux. In this study, we tested the novel hypothesis that stimulation of endogenous oxysterol synthesis would block foam cell formation induced by atherogenic lipoproteins. Macrophage synthesis of 24(S),25-epoxycholesterol, a potent LXR ligand, increased 60-fold by partial inhibition of 2,3-oxidosqualene:lanosterol cyclase (OSC), a microsomal enzyme in both the cholesterol biosynthetic pathway and the alternative oxysterol synthetic pathway. When macrophages were challenged with human hypertriglyceridemic VLDL (HTG-VLDL), cellular cholesteryl ester accumulation increased 12-fold. This was reduced dramatically, by 65%, after preincubation with an OSC inhibitor (OSCi). The HTG-VLDL-induced accumulation of macrophage TG (70-fold) was unaffected by the OSCi or exogenous 24(S),25-epoxycholesterol, an effect associated with suppression of SREBP-1 processing. By contrast, TO901317, a synthetic LXR agonist, increased cellular TG significantly and markedly increased SREBP-1 processing. OSC inhibition decreased HTG-VLDL uptake through downregulation of LDL-receptor expression, despite substantial inhibition of cholesterol synthesis. Furthermore, OSC inhibition significantly upregulated ABCA1 and ABCG1 expression, which led to enhanced macrophage cholesterol efflux, an effect mediated through LXR activation. Therefore, increased macrophage synthesis of endogenous oxysterols represents a new mechanism for the dual regulation of LXR- and SREBP-responsive genes, an approach that inhibits foam cell formation without detrimental effect on TG synthesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14512442     DOI: 10.1161/01.RES.0000097606.43659.F4

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  23 in total

1.  Interleukin-6 protects human macrophages from cellular cholesterol accumulation and attenuates the proinflammatory response.

Authors:  Eric Frisdal; Philippe Lesnik; Maryline Olivier; Paul Robillard; M John Chapman; Thierry Huby; Maryse Guerin; Wilfried Le Goff
Journal:  J Biol Chem       Date:  2011-07-08       Impact factor: 5.157

Review 2.  Liver X receptors as integrators of metabolic and inflammatory signaling.

Authors:  Noam Zelcer; Peter Tontonoz
Journal:  J Clin Invest       Date:  2006-03       Impact factor: 14.808

3.  Gold nanocrystal labeling allows low-density lipoprotein imaging from the subcellular to macroscopic level.

Authors:  Iris E Allijn; Wei Leong; Jun Tang; Anita Gianella; Aneta J Mieszawska; Francois Fay; Ge Ma; Stewart Russell; Catherine B Callo; Ronald E Gordon; Emine Korkmaz; Jan Andries Post; Yiming Zhao; Hans C Gerritsen; Axel Thran; Roland Proksa; Heiner Daerr; Gert Storm; Valentin Fuster; Edward A Fisher; Zahi A Fayad; Willem J M Mulder; David P Cormode
Journal:  ACS Nano       Date:  2013-10-17       Impact factor: 15.881

Review 4.  Therapeutic approaches to drug targets in atherosclerosis.

Authors:  Prasad G Jamkhande; Prakash G Chandak; Shashikant C Dhawale; Sonal R Barde; Priti S Tidke; Ram S Sakhare
Journal:  Saudi Pharm J       Date:  2013-11-05       Impact factor: 4.330

5.  Target identification reveals lanosterol synthase as a vulnerability in glioma.

Authors:  Richard E Phillips; Yanhong Yang; Ryan C Smith; Bonne M Thompson; Tomoko Yamasaki; Yadira M Soto-Feliciano; Kosuke Funato; Yupu Liang; Javier Garcia-Bermudez; Xiaoshi Wang; Benjamin A Garcia; Kazuhiko Yamasaki; Jeffrey G McDonald; Kivanç Birsoy; Viviane Tabar; C David Allis
Journal:  Proc Natl Acad Sci U S A       Date:  2019-03-28       Impact factor: 11.205

6.  PPARδ activation attenuates hepatic steatosis in Ldlr-/- mice by enhanced fat oxidation, reduced lipogenesis, and improved insulin sensitivity.

Authors:  Lazar A Bojic; Dawn E Telford; Morgan D Fullerton; Rebecca J Ford; Brian G Sutherland; Jane Y Edwards; Cynthia G Sawyez; Robert Gros; Bruce E Kemp; Gregory R Steinberg; Murray W Huff
Journal:  J Lipid Res       Date:  2014-05-26       Impact factor: 5.922

7.  Suppression of chronic damage in renal allografts by Liver X receptor (LXR) activation relevant contribution of macrophage LXRα.

Authors:  Eva Kiss; Zoran Popovic; Jens Bedke; Shijun Wang; Mahnaz Bonrouhi; Norbert Gretz; Paula Stettner; Daniel Teupser; Joachim Thiery; Stefan Porubsky; Judith Adams; Hermann-Josef Gröne
Journal:  Am J Pathol       Date:  2011-05-05       Impact factor: 4.307

Review 8.  Are side-chain oxidized oxysterols regulators also in vivo?

Authors:  Ingemar Björkhem
Journal:  J Lipid Res       Date:  2008-10-23       Impact factor: 5.922

Review 9.  Hypoxia in murine atherosclerotic plaques and its adverse effects on macrophages.

Authors:  Saj Parathath; Yuan Yang; Stephanie Mick; Edward A Fisher
Journal:  Trends Cardiovasc Med       Date:  2013-02-01       Impact factor: 6.677

10.  Interactions of oxidosqualene cyclase (Erg7p) with 3-keto reductase (Erg27p) and other enzymes of sterol biosynthesis in yeast.

Authors:  S Taramino; M Valachovic; S Oliaro-Bosso; F Viola; B Teske; M Bard; G Balliano
Journal:  Biochim Biophys Acta       Date:  2009-10-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.